CAST for Autism Spectrum Disorder
(CAST Trial)
Trial Summary
The trial information does not specify whether participants need to stop taking their current medications.
The research suggests that evidence-based practices (EBPs) improve outcomes for autistic children, and the ACT SMART Toolkit, which facilitates the adoption of EBPs, may support the effectiveness of treatments like CAST. Additionally, the ASD Care Pathway showed improved outcomes in psychiatric settings, indicating that structured intervention strategies can be beneficial for individuals with autism.
12345The CAST treatment, also known as COMPASS, is unique because it focuses on improving transition outcomes for students with autism by using a collaborative model that involves ongoing teacher coaching and high consultant fidelity, which has shown to improve Individualized Education Program (IEP) outcomes compared to control groups.
26789Eligibility Criteria
This trial is for autistic students with Individualized Education Programs (IEPs), their caregivers, special education teachers, and pre-employment specialists. Participants should not be planning any major life changes like moving or job transitions during the school year.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Development and Focus Groups
Focus groups with administrators, special education teachers, parents, students, and pre-employment transition specialists to integrate plans and services across settings
Field Test
Conduct a field test of CAST, making further revisions based on feedback
Randomized Controlled Trial
Conduct a small RCT and network analysis to evaluate CAST for improved postsecondary outcomes
Follow-up
Participants are monitored for postsecondary outcomes at 3 months and 1 year after high school